With the gradual increase in people's attention and demand for health, the big health industry has become a global hot spot and a new economic growth point.

The big health industry conforms to the trend of China's economic transformation and upgrading and green development. The global medical and health industry investment and financing amount is most concentrated in 2021, reaching 684.603 billion yuan in the whole year, and the largest number of investment and financing in 2019, reaching 2,044.  

iiMedia Research recently released the "2022-2023 Global and China Big Health Industry Operation Big Data and Decision Analysis Report", showing that big data and artificial intelligence technologies empower many big health industries, including public health big data, and rapid disease diagnosis. , telemedicine, identification and diagnosis, drug research and development, rehabilitation treatment, etc., improve the level of diagnosis and treatment of medical services, improve the medical experience, expand the service territory of the big health industry, and reduce service costs.

People will enjoy common high-level medical and health services, and the application of big data and artificial intelligence technology in the field of big health industry has broad prospects. China's Big Health Industry Development Economic Background: Disposable Income According to data from iiMedia Research, from 1978 to 2021, the per capita disposable income of Chinese residents has increased year by year. In 2021, the per capita disposable income of Chinese residents will be 35,000 yuan, a year-on-year increase of 9.4%. iiMedia Research analysts believe that as residents' disposable income continues to increase and basic material life is fully guaranteed, people will pay more attention to their own health, and the big health industry will usher in better development prospects.  

The economic background of the development of China's big health industry: residents' consumption and medical expenditure According to data from iiMedia Research, from 2014 to 2019, Chinese residents' per capita consumption expenditures and healthcare consumption expenditures showed a trend of simultaneous growth. In 2020, affected by the epidemic, per capita consumption expenditures and healthcare consumption expenditures both declined. A pick-up in 2021. iiMedia Research analysts believe that with the improvement of the epidemic situation and the improvement of residents' consumption level, residents' demand for the big health industry will continue to grow in the future.  

 Big data monitoring of China's big health industry revenue scale According to data from iiMedia Research, from 2014 to 2021, the overall revenue of China's big health industry will continue to grow. In 2021, the revenue will reach 8.0 trillion yuan, an increase of 8.1%, and it is expected to reach 90,000 in 2024. billion. iiMedia Research analysts believe that the development of the big health industry in China and the world is basically the same, and the demand continues to grow due to changes in the social structure, which has sustainable growth.  

 2022-2023 Development Trend of Big Health Industry The demand for medical care in China continues to increase. The State Council and the health department continue to release relevant policies to support social capital in running hospitals and participating in the reform of public hospitals, attracting capital into the hospital industry market, introducing advanced management concepts into the hospital industry through capital power, and improving the utilization of medical resources. Operational efficiency and avoid resource waste. With the outbreak of the demand for listing in the big health industry, the government's veto rate for medical and health IPOs has further increased. In the future, supervision will pay more attention to problems such as abnormal business income, incomplete internal control, or the existence of disguised transfer of interests, violations of laws and regulations, and incomplete and reasonable fundraising and investment projects. Healthcare companies should take care to avoid issues that may affect approval.